LendingTree, Inc.
For the period ended Dec 31, 2025. Filed Mar 9, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 9, 2026
TREE$35.35-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| (in thousands) | |||
| Cash flows from operating activities: | |||
| Net income (loss) and comprehensive income (loss) | $151,308 | $(41,704) | $(122,404) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities | |||
| (Gain) loss on impairments and disposal of assets | (71) | 2,584 | 5,437 |
| Amortization of intangibles | 5,190 | 5,889 | 7,694 |
| Depreciation | 16,459 | 18,300 | 19,070 |
| Non-cash compensation expense | 29,457 | 28,579 | 39,682 |
| Deferred income taxes | (129,751) | 2,793 | (4,692) |
| Bad debt expense | 264 | 171 | 1,752 |
| Amortization of debt issuance costs | 1,609 | 2,168 | 3,137 |
| Amortization of debt discount | 498 | 331 | — |
| Reduction in carrying amount of ROU asset, offset by change in operating lease liabilities | (1,926) | (2,839) | (4,404) |
| Gain on settlement of convertible debt | (266) | (9,035) | (48,562) |
| Loss on impairment of equity investments | 1,225 | 58,376 | 114,504 |
| Loss on impairment of goodwill | — | — | 38,600 |
| Loss on repayment of term loans | 7,861 | — | — |
| Changes in assets and liabilities: | |||
| Accounts receivable | (13,056) | (43,007) | 27,706 |
| Prepaid and other assets | (13,586) | (4,747) | (2,977) |
| Accounts payable, accrued expenses and other current liabilities | 19,990 | 44,581 | (5,541) |
| Income taxes receivable | (2,166) | 96 | (140) |
| Other, net | 64 | (278) | (1,291) |
| Net cash provided by operating activities | 73,103 | 62,258 | 67,571 |
| Cash flows from investing activities | |||
| Capital expenditures | (12,423) | (11,220) | (12,528) |
| Proceeds from the sale of fixed assets | 2,497 | — | — |
| Other investing activities | — | 2 | 50 |
| Net cash used in investing activities | (9,926) | (11,218) | (12,478) |
| Cash flows from financing activities | |||
| Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise of stock options | (2,789) | (2,186) | (1,088) |
| Proceeds from term loan | 450,000 | 125,000 | — |
| Repayment of term loan | (410,375) | (12,500) | (1,875) |
| Repayment and repurchase of 0.50% Convertible Senior Notes | (115,007) | (158,839) | (237,464) |
| Payment of revolver issuance costs | (1,432) | — | — |
| Payment of debt issuance costs | (5,095) | (4,300) | (1,580) |
| Payment of original issue discount on term loan | (4,000) | (3,125) | — |
| Other financing activities | — | (552) | 1 |
| Net cash used in financing activities | (88,698) | (56,502) | (242,006) |
| Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents | (25,521) | (5,462) | (186,913) |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period | 106,594 | 112,056 | 298,969 |
| Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period | $81,073 | $106,594 | $112,056 |
| Non-cash investing activities: | |||
| Increase (decrease) in capital expenditures included in accounts payable and accrued expenses | $(170) | $128 | $(377) |
| Supplemental cash flow information: | |||
| Interest paid | $37,203 | $38,203 | $23,685 |
| Income tax payments | 1,772 | 1,676 | 1,283 |
| Income tax refunds | 238 | 220 | 100 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.